Insider Selling: Synopsys (NASDAQ:SNPS) Insider Sells $574,882.88 in Stock

Posted by George Bondi on Oct 10th, 2026

Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) insider Janet Lee sold 1,144 shares of the company’s stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $502.52, for a total transaction of $574,882.88. Following the completion of the sale, the insider directly owned 16,534 shares in the company, valued at approximately $8,308,665.68. The trade was a 6.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Synopsys Trading Up 2.5%

Shares of SNPS stock opened at $509.99 on Friday. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The company has a market capitalization of $97.73 billion, a P/E ratio of 90.10, a P/E/G ratio of 2.03 and a beta of 1.21. The firm has a 50-day moving average price of $419.94 and a 200 day moving average price of $439.00. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29.

Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company’s revenue for the quarter was up 42.4% compared to the same quarter last year. During the same period in the previous year, the business earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Research analysts forecast that Synopsys, Inc. will post 10.97 earnings per share for the current fiscal year.

Synopsys declared that its Board of Directors has approved a stock repurchase program on Monday, October 5th that allows the company to buy back $1.00 billion in shares. This repurchase authorization allows the semiconductor company to purchase up to 1.1% of its stock through open market purchases. Share repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

SNPS has been the subject of several research analyst reports. Roth Capital upgraded Synopsys to a “buy” rating in a research report on Friday, September 25th. Barclays initiated coverage on Synopsys in a report on Friday, September 25th. They set an “overweight” rating on the stock. Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a report on Friday, October 2nd. Piper Sandler upgraded shares of Synopsys from a “neutral” rating to an “overweight” rating and upped their price target for the stock from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Finally, KeyCorp increased their price objective on shares of Synopsys from $600.00 to $605.00 and gave the stock an “overweight” rating in a report on Thursday, October 1st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $584.11.

Get Our Latest Stock Analysis on Synopsys

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. AGH Wealth Advisors LLC raised its position in shares of Synopsys by 4.4% during the 1st quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company’s stock valued at $226,000 after acquiring an additional 24 shares during the last quarter. Sumitomo Life Insurance Co. grew its stake in shares of Synopsys by 0.4% during the fourth quarter. Sumitomo Life Insurance Co. now owns 6,742 shares of the semiconductor company’s stock worth $3,167,000 after purchasing an additional 27 shares during the period. Elevation Wealth Partners LLC increased its holdings in Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after purchasing an additional 27 shares during the last quarter. Bar Harbor Wealth Management lifted its stake in Synopsys by 0.7% in the first quarter. Bar Harbor Wealth Management now owns 4,181 shares of the semiconductor company’s stock valued at $1,658,000 after buying an additional 31 shares during the period. Finally, Oak Grove Capital LLC boosted its holdings in Synopsys by 1.1% during the third quarter. Oak Grove Capital LLC now owns 2,898 shares of the semiconductor company’s stock worth $1,260,000 after buying an additional 32 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys News Roundup

Here are the key news stories impacting Synopsys this week:

Positive Sentiment: Bank of America reiterated a Buy rating and a $600 price target, citing Synopsys’ AI-driven growth prospects, its collaboration with OpenAI and support from the company’s share-repurchase program. Bank of America Synopsys rating
Positive Sentiment: Synopsys’ chip-design software is becoming increasingly important as AI systems make semiconductors more complex. Nvidia’s $2 billion investment and planned agentic-AI design and verification workflows reinforce the company’s strategic position. Nvidia and Synopsys AI partnership
Positive Sentiment: A multiyear agreement with Amazon reportedly valued at more than $1 billion highlights strong demand for Synopsys’ tools and Amazon’s expanding AI-chip ambitions. The company also authorized a $1 billion buyback, which could support earnings per share and signal management’s confidence in long-term value.
Positive Sentiment: Recent fundamentals remain strong: quarterly EPS of $3.91 exceeded the $3.67 consensus, revenue reached $2.48 billion versus $2.44 billion expected, and revenue grew 42.4% year over year. Analysts maintain a generally favorable view, with a consensus “Moderate Buy” rating and an average target near $584.
Neutral Sentiment: Synopsys is reportedly exploring potential work with Chinese AI laboratories on chip-design technology. The opportunity could expand its addressable market, but China-related export controls and geopolitical restrictions may limit the commercial benefit. Synopsys Chinese AI laboratory report
Neutral Sentiment: Reported short interest was listed at zero shares, implying no meaningful short-position pressure; however, the figure conflicts with the article’s description of a significant increase and should be treated cautiously.
Negative Sentiment: Insiders have recently sold shares, including Janet Lee’s 1,144-share sale worth approximately $575,000 and CFO Sudhindra Kankanwadi’s larger transactions. The sales do not establish a change in business outlook, but they may create a near-term sentiment overhang.
Negative Sentiment: At roughly 89–90 times earnings, Synopsys is priced for substantial growth. Any slowdown in EDA demand, acquisition-related leverage or disappointment after future earnings could make the stock vulnerable despite strong operating results.

About Synopsys

(Get Free Report)

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.